AB Science reports the outcome from the interim analysis of study AB09004 in Alzheimer’s Disease

    NEXT STORY
    Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis
    PREV STORY
    OSE Immunotherapeutics Announces Results of 2019 Annual Shareholder Meeting
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    NewLink Genetics Announces EU Regulatory Committee (CHMP) Recommendation for Conditional Marketing Authorization for Ebola Vaccine V920 (ERVEBO®)

    author_avatar
    NASDAQ Market News

    Inivata Receives Medicare Final Coverage Decision for InVisionFirstTM-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer

    author_avatar
    NASDAQ Market News

    Delcath Systems Announces Completion of Underwritten Public Offering

    author_avatar
    NASDAQ Market News